Franck A. Atienzar

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

Helga H.J. Gerets, Karen Tilmant, Brigitte Gerin et al. · Cell Biology and Toxicology · 2012 · 679 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

The Use of Real-Time Cell Analyzer Technology in Drug Discovery: Defining Optimal Cell Culture Conditions and Assay Reproducibility with Different Adherent Cellular Models

Franck A. Atienzar, Karen Tilmant, Helga H.J. Gerets et al. · SLAS DISCOVERY · 2011 · 103 citations · Full text

Engineering, Biomedical Engineering, Cell Biology +17

Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: A preliminary study using a multiplexing approach

Helga H.J. Gerets, Étienne Hanon, Miranda Cornet et al. · Toxicology in Vitro · 2008 · 70 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans

Franck A. Atienzar, Eric Novik, Helga H.J. Gerets et al. · Toxicology and Applied Pharmacology · 2013 · 56 citations

Pharmacy, Pharmacology, Toxicology +17

Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology Investigations

Franck A. Atienzar, Helga H.J. Gerets, Karen Tilmant et al. · Biosensors · 2013 · 45 citations · Full text

Pharmacy, Pharmacology, Toxicology +17